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We used whole-genome sequencing to investigate a dualgenotype outbreak of measles occurring after the XXI Olympic Winter Games in Vancouver, Canada. By sequencing 27 complete genomes from H1 and D8 genotype measles viruses isolated from outbreak cases, we estimated the virus mutation rate, determined that person-to-person transmission is typically associated with 0 mutations between isolates, and established that a single introduction of H1 virus led to the expansion of the outbreak beyond Vancouver. This is the largest measles genomics project to date, revealing novel aspects of measles virus genetics and providing new insights into transmission of this reemerging viral pathogen.
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Endemic transmission of measles virus (MV) was halted in Canada in 1998 [1] and in the United States in 2000 [2] ; however, since reaching an historic low of 278 417 cases worldwide in 2008, measles incidence has increased annually in almost every World Health Organization (WHO) region [3] .
The WHO recognizes mass gatherings as potential venues for measles transmission, and measles outbreaks have previously been linked to large religious events [4, 5] and sporting events [6] [7] [8] Measles transmission is difficult to assess through epidemiological information alone; on average, one third of cases have no identifiable link to another case [9] . Previous work indicates that sequencing of the MV phosphoprotein (P) and hemagglutinin (H) genes may be useful in revealing transmission routes, owing to their finer resolution, compared with standard genotyping [10] . More recently, whole-genome sequencing (WGS) has proven capable of resolving individual transmission events within outbreaks of bacterial pathogens, as well as providing insight into the evolutionary dynamics and pathogenesis of bacterial and viral disease agents. To explore the utility of WGS in a measles outbreak, we performed the first genomic epidemiology investigation of this reemerging virus.
METHODS

Epidemiological Data
We defined the outbreak period as lasting from 1 incubation period (14 days) before the first patient's rash onset to 2 incubation periods after the last patient's rash onset. The H1 outbreak spanned 23 February to 26 May; the D8 outbreak spanned 5 March to 11 May. We presumed that exposures occurred 7-21 days before rash onset and defined periods of communicability as the 4-day intervals before and after rash appearance.
Cases presenting between 23 February and 26 May were classified as confirmed, clinical/probable, and suspected, according to the British Columbia Centre for Disease Control Communicable Disease Manual. Patient data were collected by regional health authorities, and contact between 2 cases was recorded when the individuals shared a household, reported a workplace or other relationship, or visited a common indoor location during an individual's infectious period.
Laboratory Methods
Nasopharyngeal swab, blood, and urine samples collected from the 71 cases with a laboratory diagnosis of measles were stored at −80°C. Genotyping of MV RNA-positive samples (n = 45) was performed at Canada's National Microbiology Laboratory, according to WHO guidelines [11] ; sequences of the 42 successfully genotyped samples were submitted to the Measles Nucleotide Surveillance Database (MeaNS). To generate sufficient material for WGS, MVs from the 45 RNA-positive cases were cultured in a Vero/hSLAM cell line in minimal essential medium supplemented with HEPES, penicillin, fungizone, ampicillin, and gentamicin. After splitting, cells were incubated for 24 hours before inoculation with 0.5-1 mL of specimen. Following culture, viral RNA was isolated using NucliSens easyMAG. Of the 45 MV RNA-positive cultures, 30 yielded sufficient genetic material for WGS.
To generate overlapping amplicons for Sanger sequencing, we designed primers based on available MV genomes (Supplementary Table 1A ); nested polymerase chain reaction (PCR) was used to close gaps in the genomes (Supplementary  Table 1B ). Sanger sequencing was performed at Canada's Michael Smith Genome Sciences Centre on an ABI 3730xls. Amplicon sequences from the 30 genomes were trimmed to remove low-quality bases and were assembled using Geneious; we generated high-quality consensus sequences for 27 of 30 samples. The average percentage of bases with a quality score of ≥40 was 92% (range, 76%-96%), and the average depth of coverage was 3.4 (range, 2.6-3.8). The 27 high-quality assembled genomes were manually reviewed and chromatograms at all single-nucleotide variant (SNV) positions were inspected for accuracy. We deposited representative consensus sequences of 1 H1 and 1 D8 genome in GenBank under accession numbers KJ018970 (MVi/BritishColumbia.CAN/12.10/1[H1]) and KJ018971 (MVi/BritishColumbia.CAN/13.10/1[D8]), which correspond to MVs isolated from H1 cases 20A, 48A, 49, and 73 and D8 cases 9 and 28 ( Figure 1 ). Positions 1-26 and 15 866-15 894 of these genomes reflect the sequencing primers used rather than sequenced MV; however, these positions are 100% identical across other wild-type MVs sequenced to date.
We used a set of custom reverse transcription (RT)-PCR assays targeting 4 SNVs identified from whole-genome data to confirm the presence of the SNVs in the 27 sequenced genomes and to type samples from 22 additional PCR-positive clinical specimens in which viral titers were too low for WGS. We assayed the samples by using the primers in Supplementary  Table 2 and AgPath-ID One-Step RT-PCR reagents.
Evolutionary Analyses
We used the DataMonkey single-likelihood ancestor counting package [12] and the F81 evolutionary model to calculate dN/ dS; sufficient diversity for the analysis was present only in the P and large (L) genes of H1 MVs. We inputted complete genome sequences of 17 H1 MV isolates (1 per patient) and their date of sampling into BEAST [13] for evolutionary analysis. We report a mutation rate calculation, using the general reversible substitution (GTR) model, an exponential relaxed molecular clock, and a coalescent:exponential growth tree prior (the XML file is available at: http://figshare.com/articles/BEAST_XML_File_ H1_Measles_Outbreak_Mutation_Rate_Calculation/1157872). We also evaluated all combinations of the (1) GTR or HKY models; (2) strict, log-normal relaxed, and exponential relaxed clocks; and (3) ). The University of British Columbia's biosafety and ethics committees reviewed and approved the study.
RESULTS AND DISCUSSION
Of the 82 outbreak cases, 45 (54.9%) were PCR positive, containing MV nucleic acid for downstream genetic analyses (Table 1) . We successfully genotyped 42 outbreak cases (51.2%), using Sanger sequencing of the C-terminal 456 bp of the nucleoprotein (N) gene. Genotypes were inferred for a further 25 cases (30.5%) through reported contact with a genotyped case. The H1 outbreak comprised 61 cases across British Columbia, while the 6 D8 cases were restricted to Vancouver. Fifteen cases could not be assigned to a genotype. BLAST analysis of the N gene fragments indicated that the H1 MV was 99% identical to that of MV recently isolated in China; the D8 MV was 100% identical to that of MV isolated in locations including Italy, the United States, and India.
As a precursor to WGS, the 45 PCR-positive specimens were cultured; ultimately, 30 specimens yielded Sanger WGS data. We determined complete 15 894-bp genomes for 27 MVs: 24 H1 isolates from 17 cases and 3 D8 isolates from 3 cases. Sequence data from the 3 remaining isolates was of insufficient quality and coverage for assembly. Among H1 isolates, we identified 10 SNVs relative to the outbreak consensus sequence (KJ018970); 4 SNVs were observed among D8 isolates relative to its consensus (KJ018971; Figure 1A and Supplementary Table 3 ). SNVs were largely synonymous substitutions, and we estimated the mean dN/dS for the H1 P and L genes as 0.101 and 0.641, respectively; no positively selected sites were detected. Using the larger data set of H1 genome sequences, we estimated the viral mutation rate at 1.87 × 10 −6 per base per genome replication, which is lower than rates estimated from previous analyses of single genes from MV separated in space and time [14] estimates derived from H genes sequenced in a regional outbreak [15] . Seven cases had 2 MV genomes sequenced, each cultured from a different clinical sample taken concurrently. Withinhost genetic diversity was observed in cases 20 and 48; in the other 5 cases, both genomes were 100% identical (Supplementary Table 4 ). To establish whether WGS could provide insight into the outbreak's transmission dynamics, we next examined the genomic data in the context of available epidemiological data. Genomic data from bacterial outbreaks suggest that epidemiologically linked isolates differ by <5 SNVs, frequently by 0 SNVs. Of the 3 sequenced D8 cases, 2 were linked through household contact; their genomes were 100% identical (Supplementary Figure 1) . Among the larger data set of sequenced H1 genomes, 4 of 10 SNVs were detected in >1 case, suggesting that they might be useful markers of transmission. We developed a PCR assay targeting these 4 SNVs to type them in the clinical specimens from the H1 cases for which MV nucleic acid was available but at titers too low for WGS. The assay successfully typed 14 of these 22 cases at all 4 SNVs (Supplementary Table 4) ; results for the remaining 8 cases were inconclusive. The 17 cases analyzed using WGS were also typed to confirm the presence of the SNVs; in all cases, the assay supported the WGS results. Together, the detection of these SNVs in both cultured, sequenced MV and MV from uncultured clinical specimens suggests that the SNVs are not artifacts of culture or amplification.
We assigned each of the 31 H1 cases with WGS data and/or SNV assay results to one of the 6 viral lineages, A-F, defined by the 4 SNVs ( Figure 1B and Supplementary Table 4) . Although lineage assignment was only possible for 31 of the 61 H1 cases, the genomic data allowed us to draw several conclusions that would not have been possible had we only performed traditional genotyping.
First, we detected 3 lineages-A, B, and F-within the first 2 weeks of the outbreak. This observed diversity suggests that although purifying selection exerts a strong effect on wild-type Figure 1 . A, Summary of the genomic variation across 27 sequenced H1 and D8 measles virus complete genomes. We sequenced 24 H1 genotype viruses from 17 cases (numbered at left; A/B indicates multiple sequenced samples from one case). Across the 15 894-bp genomes, we observed single-nucleotide variants (SNVs) at 10 positions in 4 genes: phosphoprotein (P), matrix (M), fusion (F), and large (L). The asterisks indicate an SNV shared by multiple cases, defining distinct genetic lineages among H1 viruses. Genomes of 3 D8 genotype viruses from 3 cases were completely sequenced; 4 SNVs in 2 genes were found. H1 case labels are colored according to the dendrogram in panel B to indicate which genetic lineage they belong to. Full details of the SNV positions and wild-type bases can be found in Supplementary Table 3; Supplementary Table 4 provides SNV sequences for each case, including those only interrogated with a SNV assay and not whole-genome sequencing (WGS). B, Six viral lineages were observed among H1 measles virus. The dendrogram indicates the evolutionary relationships between the 6 H1 viral lineages, A-F; shown in each circle are the 4 lineage-defining SNVs. Each lineage is separated from its ancestor by a single SNV. C, Genomic epidemiology of the outbreak of H1 measles virus infection. Of the 61 H1 cases occurring provincewide, 31 could be assigned to one of the 6 lineages and are colored according to the scheme in panel C; one case had both lineages A and F, indicated with partial coloring. Nodes are arranged on the x-axis based on date of rash onset; clustering along the y-axis is by geographic region within the province. Lines connect cases with a reported epidemiological linkage.
MV, mutations arising over the short time scale of an outbreak yield enough diversity to finely distinguish spatiotemporal clusters of cases.
Second, we observed that all cases outside Greater Vancouver belonged to lineage D or its descendant lineage E ( Figure 1C )-one northern case belonging to lineage F was exposed while in the Vancouver area. This spatial clustering suggests that a single exportation of MV out of Vancouver led to the provincewide spread of the outbreak. All affected rural communities were located along or near Highway 97, the only vehicular route connecting Vancouver to British Columbia's northern region via the province's interior.
Finally, we established that person-to-person MV transmission is typically characterized by 100% genomic identity between cases, as was observed with the D8 cases. Although we had few instances in which MV from both members of an H1 epidemiological dyad had been sequenced or typed, we did observe that MV from 4 household contacts of one coprimary case were identical across their complete genomes. MA from a fifth individual who visited the household was SNV typed as belonging to the same lineage; MV from 2 other visitors and a nosocomial contact had no/insufficient nucleic acid for analysis. This is the first application of genomic epidemiology to the reemerging MV and is, to our knowledge, the largest measles genomics effort to date, generating 27 complete genomes. In the context of an outbreak associated with a mass gathering-likely the result of 2 separate importations of MV from Olympics visitors-we demonstrated that, despite the limited species-level genetic diversity imposed upon MV by purifying selection, WGS of samples taken over a short time frame revealed enough variation to draw conclusions about the outbreak's dynamics that would not have been possible with standard genotyping. We were limited by only having access to small aliquots of clinical specimens remaining after routine testing. Had genomic material been available from more cases, identification of transmission events beyond those suggested by the epidemiological investigation likely would have been possible. Availability of nucleic acid for WGS will be the limiting step in future genomic epidemiology investigations of MV; however, with new technologies for sequencing directly from clinical samples, we anticipate that generating high-quality sequence for more cases will be feasible, with the resulting data providing new insights into the transmission and population genetics of this reemerging pathogen.
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